Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults

Eitemau Tebyg

• A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults
  gan: Nagai, Hideaki, et al.
  Cyhoeddwyd: (2010)
• Evaluation of immune response following one dose of an AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older
  gan: Ikematsu, Hideyuki, et al.
  Cyhoeddwyd: (2012)
• An assessment of prime‐boost vaccination schedules with AS03(A)‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults
  gan: Gillard, Paul, et al.
  Cyhoeddwyd: (2012)
• Long-term booster schedules with AS03(A)-adjuvanted heterologous H5N1 vaccines induces rapid and broad immune responses in Asian adults
  gan: Gillard, Paul, et al.
  Cyhoeddwyd: (2014)
• Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies
  gan: Garcia-Sicilia, José, et al.
  Cyhoeddwyd: (2015)